To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.
PNNL biomedical scientist Ernesto Nakayasu brings expertise in host-pathogen interactions and the interconnection between the immune response and cellular metabolism to provide constructive review for submitted manuscripts.
After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.
A team of researchers is working to expand our uranium chemistry understanding using a surprising tool: lasers. This capability gives never-before-seen insight into uranium gas-phase oxidation during nuclear explosions.
A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.
Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
The world’s largest scientific society honored Sue B. Clark, a PNNL and WSU chemist, for contributions toward resolving our legacy of radioactive waste, advancing nuclear safeguards, and developing landmark nuclear research capabilities.
While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.
PNNL researchers demonstrated a nanoscale analysis tool to map isotopes to location in low-enriched uranium-molybdenum fuel plates for use in nuclear research reactors.
The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.
When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?
PNNL Laboratory Director Steve Ashby attended an event marking the 20th anniversary of the Department of Energy’s National Nuclear Security Administration Nuclear Smuggling Detection and Deterrence program.
